Showing 1 - 9 of 9
Persistent link: https://www.econbiz.de/10010259652
Persistent link: https://www.econbiz.de/10011990561
Persistent link: https://www.econbiz.de/10008355089
Persistent link: https://www.econbiz.de/10008358468
Persistent link: https://www.econbiz.de/10000096421
In this article we describe how reimbursement cost-effectiveness thresholds, per unit of health benefit, whether set explicitly or observed implicitly via historical reimbursement decisions, serve as a signal to firms about the commercial viability of their R&D projects (including candidate...
Persistent link: https://www.econbiz.de/10010848921
Persistent link: https://www.econbiz.de/10007607643
Persistent link: https://www.econbiz.de/10014445526
In this article we describe how reimbursement cost-effectiveness thresholds, per unit of health benefit, whether set explicitly or observed implicitly via historical reimbursement decisions, serve as a signal to firms about the commercial viability of their R&D projects (including candidate...
Persistent link: https://www.econbiz.de/10008459671